Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae - PubMed (original) (raw)
Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae
G A Papanicolaou et al. Antimicrob Agents Chemother. 1990 Nov.
Abstract
Klebsiella pneumoniae isolates from 11 patients at the Miriam Hospital were identified as resistant to cefoxitin and ceftibuten as well as to aztreonam, cefotaxime, and ceftazidime. Resistance could be transferred by conjugation or transformation with plasmid DNA into Escherichia coli and was due to the production of a beta-lactamase with an isoelectric point of 8.4 named MIR-1. In E. coli, MIR-1 conferred resistance to aztreonam, cefotaxime, ceftazidime, ceftibuten, ceftriaxone, and such alpha-methoxy beta-lactams as cefmetazole, cefotetan, cefoxitin, and moxalactam. In vitro, MIR-1 hydrolyzed cephalothin and cephaloridine much more rapidly than it did penicillin G, ampicillin, or carbenicillin. Cefotaxime was hydrolyzed at 10% the rate of cephaloridine. Cefoxitin inactivation could only be detected by a microbiological test. The inhibition profile of MIR-1 was similar to that of chromosomally mediated class I beta-lactamases. Potassium clavulanate had little effect on cefoxitin or cefibuten resistance and was a poor inhibitor of MIR-1 activity. Cefoxitin or imipenem did not induce MIR-1. The gene determining MIR-1 was cloned on a 1.4-kb AccI-PstI fragment. Under stringent conditions, probes for TEM-1 and SHV-1 genes and the E. coli ampC gene failed to hybridize with the MIR-1 gene. However, a provisional sequence of 150 bp of the MIR-1 gene proved to be 90% identical to the sequence of ampC from Enterobacter cloacae but only 71% identical to that of E. coli, thus explaining the lack of hybridization to the E. coli ampC probe. Plasmid profiles of the 11 K. pneumoniae clinical isolates were not identical, but each contained a plasmid from 40 to 60 kb that hybridized with the cloned MIR-1 gene. Both transfer-proficient and transfer-deficient MIR-1 plasmids belonged to the N incompatibility group. Thus, the resistance of these K. pneumoniae strains was the result of plasmid acquisition of a class I beta-lactamase, a new resistance determinant that expands the kinds of beta-lactam resistance capable of spread by plasmid dissemination among clinical isolates.
Similar articles
- Molecular characterization of a new plasmid-encoded SHV-type beta-lactamase (SHV-2 variant) conferring high-level cefotaxime resistance upon Klebsiella pneumoniae.
Podbielski A, Schönling J, Melzer B, Warnatz K, Leusch HG. Podbielski A, et al. J Gen Microbiol. 1991 Mar;137(3):569-78. doi: 10.1099/00221287-137-3-569. J Gen Microbiol. 1991. PMID: 2033379 - Identification of a novel plasmid-mediated beta-lactamase with chromosomal cephalosporinase characteristics from Klebsiella pneumoniae.
Tzouvelekis LS, Tzelepi E, Mentis AF, Tsakris A. Tzouvelekis LS, et al. J Antimicrob Chemother. 1993 May;31(5):645-54. doi: 10.1093/jac/31.5.645. J Antimicrob Chemother. 1993. PMID: 8335495 - Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.
Bradford PA, Urban C, Mariano N, Projan SJ, Rahal JJ, Bush K. Bradford PA, et al. Antimicrob Agents Chemother. 1997 Mar;41(3):563-9. doi: 10.1128/AAC.41.3.563. Antimicrob Agents Chemother. 1997. PMID: 9055993 Free PMC article. - Novel, plasmid-encoded, TEM-derived extended-spectrum beta-lactamase in Klebsiella pneumoniae conferring higher resistance to aztreonam than to extended-spectrum cephalosporins.
Arlet G, Rouveau M, Fournier G, Lagrange PH, Philippon A. Arlet G, et al. Antimicrob Agents Chemother. 1993 Sep;37(9):2020-3. doi: 10.1128/AAC.37.9.2020. Antimicrob Agents Chemother. 1993. PMID: 8239625 Free PMC article. - AmpC beta-lactamases.
Jacoby GA. Jacoby GA. Clin Microbiol Rev. 2009 Jan;22(1):161-82, Table of Contents. doi: 10.1128/CMR.00036-08. Clin Microbiol Rev. 2009. PMID: 19136439 Free PMC article. Review.
Cited by
- Population-based laboratory surveillance for AmpC beta-lactamase-producing Escherichia coli, Calgary.
Pitout JD, Gregson DB, Church DL, Laupland KB. Pitout JD, et al. Emerg Infect Dis. 2007 Mar;13(3):443-8. doi: 10.3201/eid1303.060447. Emerg Infect Dis. 2007. PMID: 17552098 Free PMC article. - Detection of Plasmid-Mediated β-Lactamase Genes and Emergence of a Novel AmpC (CMH-1) in Enterobacter cloacae at a Medical Center in Southern Taiwan.
Ku YH, Lee MF, Chuang YC, Yu WL. Ku YH, et al. J Clin Med. 2018 Dec 20;8(1):8. doi: 10.3390/jcm8010008. J Clin Med. 2018. PMID: 30577544 Free PMC article. - Salmonella enteritidis: AmpC plasmid-mediated inducible beta-lactamase (DHA-1) with an ampR gene from Morganella morganii.
Barnaud G, Arlet G, Verdet C, Gaillot O, Lagrange PH, Philippon A. Barnaud G, et al. Antimicrob Agents Chemother. 1998 Sep;42(9):2352-8. doi: 10.1128/AAC.42.9.2352. Antimicrob Agents Chemother. 1998. PMID: 9736562 Free PMC article. - Establishment of in vitro susceptibility testing methodologies and comparative activities of piperacillin in combination with the penem {beta}-lactamase inhibitor BLI-489.
Petersen PJ, Jones CH, Venkatesan AM, Mansour TS, Projan SJ, Bradford PA. Petersen PJ, et al. Antimicrob Agents Chemother. 2009 Feb;53(2):370-84. doi: 10.1128/AAC.01047-08. Epub 2008 Nov 10. Antimicrob Agents Chemother. 2009. PMID: 19001109 Free PMC article. - Chromosomally encoded ampC-type beta-lactamase in a clinical isolate of Proteus mirabilis.
Bret L, Chanal-Claris C, Sirot D, Chaibi EB, Labia R, Sirot J. Bret L, et al. Antimicrob Agents Chemother. 1998 May;42(5):1110-4. doi: 10.1128/AAC.42.5.1110. Antimicrob Agents Chemother. 1998. PMID: 9593136 Free PMC article.
References
- J Gen Microbiol. 1972 Oct;72(3):543-52 - PubMed
- Virology. 1972 Apr;48(1):145-55 - PubMed
- Antimicrob Agents Chemother. 1972 Apr;1(4):283-8 - PubMed
- J Bacteriol. 1974 Sep;119(3):1072-4 - PubMed
- J Gen Microbiol. 1975 May;88(1):169-78 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous